News & Updates
Showing Dermatology articles
Showing
Show Multimedia Only

PSOARING trials boost potential of tapinarof for plaque psoriasis
21 Jan 2022
byAudrey Abella
The nonsteroidal topical aryl hydrocarbon receptor (AHR)-modulating agent tapinarof 1% trumped a vehicle control cream in reducing the severity and manifestations of plaque psoriasis, according to the phase III PSOARING 1 and 2 trials.
21 Jan 2022

Changes in MetS diagnosis affects psoriasis risk
28 Dec 2021
The risk of psoriasis is elevated in patients with continuous metabolic syndrome (MetS) and in those with newly developed MetS, a recent study has found. In contrast, such risk is absent in individuals with only a history of MetS.
28 Dec 2021







